These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17030228)

  • 1. The role of leukotrienes in airway inflammation.
    Ogawa Y; Calhoun WJ
    J Allergy Clin Immunol; 2006 Oct; 118(4):789-98; quiz 799-800. PubMed ID: 17030228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
    Montuschi P; Sala A; Dahlén SE; Folco G
    Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes?
    Riccioni G; Di Ilio C; D'Orazio N
    Ann Clin Lab Sci; 2004; 34(2):138-42. PubMed ID: 15228224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
    Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotrienes and inflammation.
    Busse WW
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S210-3; discussion S247-8. PubMed ID: 9647601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl-leukotrienes in asthmatic airway smooth muscle cell hyperplasia.
    Bossé Y; Stankova J; Rola-Pleszczynski M
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):16-21. PubMed ID: 19205280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene modifiers in asthma management.
    Capra V; Rovati GE
    IDrugs; 2004 Jul; 7(7):659-66. PubMed ID: 15243868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukotriene agents for the treatment of lung disease.
    Scott JP; Peters-Golden M
    Am J Respir Crit Care Med; 2013 Sep; 188(5):538-44. PubMed ID: 23822826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in therapy with antileukotriene drugs.
    Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
    Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Wong WS; Zhu H; Liao W
    Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Leukotrienes and Leukotriene Modifiers in Asthma.
    Montuschi P
    Pharmaceuticals (Basel); 2010 Jun; 3(6):1792-1811. PubMed ID: 27713330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains.
    Austen KF
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):182-7. PubMed ID: 17481553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
    Christie PE; Henderson WR
    Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
    Rubin P; Mollison KW
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.